脊柱透明细胞型脑膜瘤:12例患者的长期随访临床研究
该回顾性研究分析了2006年1月至2018年1月在本院治疗的12例脊柱透明细胞型脑膜瘤(CCM)患者的临床特征、影像学、诊断、治疗和转归,并复习文献。CCM占本院治疗的脊柱脑膜瘤的2.8%,最常见于腰椎(12例中7例),诊断时平均年龄显著低于脊柱脑膜瘤患者(28.8±13.4岁 vs. 54.0±14.4岁)。随访期间5例(41.7%)复发;年轻患者无进展生存期显著短于年长患者。文献复习显示已报告55例脊柱CCM,19例(38.0%)出现局部复发,5年无进展生存率为33.3%。
要点
- 脊柱CCM占本院脊柱脑膜瘤的2.8%,最常见于腰椎(12例中7例)。
- 诊断时平均年龄显著低于脊柱脑膜瘤患者(28.8±13.4岁 vs. 54.0±14.4岁)。
- 随访期间5例(41.7%)复发,年轻患者无进展生存期显著更短。
核心结论
- 脊柱CCM是极罕见的肿瘤,好发于年轻患者,复发率高。
- 虽然全切被认为是理想治疗,但对于次全切患者或年轻患者(无论切除范围),可考虑放疗。
- 多年对整个神经轴的密切随访至关重要。
研究设计与样本
- 回顾性分析2006年1月至2018年1月在本院治疗的12例脊柱CCM患者的临床特征、影像学表现、诊断、治疗和转归。
- 同时复习已报告的脊柱CCM数据。
主要发现
- CCM占本院治疗的脊柱脑膜瘤的2.8%(12例中)。
- 最常见部位为腰椎(12例中7例)。
- 诊断时平均年龄显著低于脊柱脑膜瘤患者(28.8±13.4岁 vs. 54.0±14.4岁)。
- 随访期间5例(41.7%)出现肿瘤复发;Kaplan-Meier分析显示年轻患者无进展生存时间显著短于年长患者。
- 文献复习显示已报告55例脊柱CCM,19例(38.0%)出现局部复发,5年无进展生存率为33.3%。
临床怎么用
- 作者认为全切是理想治疗,对于次全切患者或年轻患者(无论切除范围),可考虑放疗。
- 作者强调多年对整个神经轴进行密切随访至关重要。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Clear cell meningioma (CCM) is a rare histologic subtype of meningioma. The features of CCMs have commonly been based on intracranial cases. However, CCMs in the spinal cord are even rarer, and their natural history, management, and prognosis remain ill-defined. METHODS: From January 2006 to January 2018, 12 patients with spinal CCM were treated in our hospital. The clinical features, radiologic findings, diagnosis, treatment, and outcome of these patients were analyzed retrospectively. Additionally, we performed a review of the reported data on spinal CCMs. RESULTS: CCMs accounted for 2.8% of all the spinal meningiomas treated in our hospital. The most common localization of this disease was the lumbar region (7 of 12). The mean age at diagnosis was significantly younger than that of patients with spinal meningiomas (28.8 ± 13.4 years vs. 54.0 ± 14.4 years). During the follow-up period, 5 patients (41.7%) experienced tumor recurrence. Kaplan-Meier analysis showed that younger patients had a significantly shorter progression-free survival time than older patients. The review of the reported data showed that 55 cases of spinal CCMs had been reported. Nineteen patients (38.0%) had developed local recurrence, with a 5-year progression-free survival rate of 33.3%. CONCLUSIONS: Spinal CCMs are extremely rare tumors with a predilection to affect younger patients and have a high recurrence rate. Although gross total resection is considered to be the optimal treatment, radiotherapy could be considered for patients who had undergone subtotal resection or for younger patients, regardless of the extent of removal. Close follow-up of the entire neuraxis for years is crucial.
引用
- Li J, Zhang S, Wang Q, et al. Spinal Clear Cell Meningioma: Clinical Study with Long-Term Follow-Up in 12 Patients. World Neurosurg. 2018. PMID: 30342264. doi:10.1016/j.wneu.2018.10.064
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。